May 20, 2020 / 2:32 PM / 17 days ago

BRIEF-India's Strides Pharma Science Posts March Quarter Consol Net Loss

May 20 (Reuters) - Strides Pharma Science Ltd:

* MARCH QUARTER CONSOL NET LOSS 2.07 BILLION RUPEES VERSUS PROFIT OF 595 MILLION RUPEES LAST YEAR

* MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 6.19 BILLION RUPEES VERSUS 6.16 BILLION RUPEES LAST YEAR

* STRIDES PHARMA SCIENCE - RECOMMENDED FINAL DIVIDEND OF 2 RUPEES PER SHARE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below